採用
Caribou Biosciences

Caribou Biosciences
CRISPR genome editing company
Gene Editing
Cell Therapy
Immunotherapy
Biotechnology
Drug Development
Open Positions
7 positions
VP, General Manager Lending
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
VP
Full-time
$200,000 - $240,000
Healthcare
Equity
1w ago
Titling Agent
Denver, Colorado, United States
On-site
Full-time
$49,920 - $54,080
Healthcare
Equity
1w ago
Senior Manager, Go-To-Market Operations
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Lead
Full-time
$120,000 - $150,000
Healthcare
Equity
1w ago
Principal Product Manager - Horizon Initiatives
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Staff
Full-time
$173,000 - $217,000
Equity
1w ago
Manager, Sales Support
Denver, Colorado, United States
On-site
Lead
Full-time
$80,000 - $100,000
Equity
1w ago
Don't See What You're Looking For?
Remote - U.S.
On-site
Full-time
1w ago
Director, Direct Mail Growth
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Director
Full-time
$140,000 - $175,000
Equity
1w ago
Products & Services
CB
CB-010
Cell Therapy
CB
CB-011
Cell Therapy
CB
CB-012
Cell Therapy
CH
chRDNA Platform
Platform Technology
CR
CRISPR Manufacturing Services
Manufacturing Services
GE
Genome Editing Tools
Research Tools
Similar Companies

Clover Health
Public
Technology-driven health insurance company
Franklin, Tennessee
501-1,000
75 open jobs

Medtronic
Public
Medical device company.
Minneapolis, Minnesota, United States
10,001+
776 open jobs

CSX
Focused on rail transportation and real estate in North America, among other industries.
Auckland, Auckland, New Zealand
1-50

Equinox
Series B
Luxury fitness club chain
Newport Beach, California, United States
1-50

Natera
Public
Specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health.
Austin, Texas that specializes
1,001-5,000
140 open jobs

CRISPR Therapeutics
Public
Leading company in the technology industry
Cambridge, Massachusetts, United States
201-500
Valuation $2.9B
9 open jobs
News & Buzz
All
X
News
HN
YouTube
Caribou Biosciences (NASDAQ:CRBU) Shares Up 0.6% - Should You Buy? - MarketBeat
Source: MarketBeat
google-news
·
1mo ago
Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why - Yahoo Finance
Source: Yahoo Finance
google-news
·
1mo ago
CRISPR PD-1 knockout allogeneic CAR-T matches autologous - CRISPR Medicine News
Source: CRISPR Medicine News
google-news
·
3mo ago
Caribou’s off-the-shelf CAR-T therapy shows promise in lymphoma study - statnews.com
Source: statnews.com
google-news
·
4mo ago
Caribou Biosciences: A Much Anticipated Data Readout Does Not Quite Get My Buy - Seeking Alpha
Source: Seeking Alpha
google-news
·
4mo ago
More (5 remaining)
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Reviews
3.7
1 reviews
Work Life Balance
3.5
Compensation
3.5
Culture
3.5
Career
4.0
Management
3.5
75%
Recommend to a Friend
Pros
Clinical-stage biopharmaceutical company with promising pipeline
Multiple lead product candidates in development
Focus on hematologic malignancies and solid tumors
Cons
Limited review data available
No specific concerns mentioned
Potential early-stage company risks
Salary Ranges
22 data points
Mid/L4
Senior/L5
Mid/L4
2 reports
$195,000
total / year
Base
$150,000
Stock
-
$195,000
$195,000
Interview Experience
52 interviews
Difficulty
3.2
/ 5
Duration
2-5w
Offer Rate
42%
Experience
Positive 61%
Neutral 24%
Negative 15%
Interview Process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Contact & Location